TV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Grupo Televisa SAB is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some short-term technical strength, but the broader picture is mixed: analysts are still Neutral, hedge funds are selling aggressively, there is no supportive news catalyst, and no strong proprietary buy signal is present. For an impatient buyer who does not want to wait for a better entry, this is not the right setup.
TV is trading at 2.88, just above the first resistance area around 2.864 and near the second resistance at 2.944. The MACD histogram is positive and expanding, which supports short-term upward momentum. However, RSI_6 at 73 suggests the stock is somewhat stretched in the near term, and the moving averages are converging, which points to a lack of strong trend confirmation. Overall, the technical setup is mildly bullish short term but not strong enough for an aggressive long-term entry.
["MACD is positive and expanding, indicating improving short-term momentum.", "Open interest put-call ratio of 0.39 suggests a bullish leaning in positioning.", "Price is trading above the pivot level and near near-term resistance breakout territory.", "Consensus analyst rating remains Neutral rather than negative."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "Hedge funds are selling, with selling increasing 463.97% over the last quarter.", "Analysts recently cut the price target from $3.70 to $3.20, showing reduced upside expectations.", "RSI is elevated, suggesting the stock is extended in the short term.", "No AI Stock Picker or SwingMax buy signal is present today.", "No recent congress trading data or insider buying support the thesis."]
No usable latest-quarter financial snapshot was provided, so there is no reliable quarter-by-quarter growth assessment available from the data. Because the financials are missing, there is no evidence here of accelerating revenue, earnings, or margin improvement to support a long-term buy decision.
UBS lowered its price target to $3.20 from $3.70 on 2026-05-11 and kept a Neutral rating. That followed an earlier upgrade in target on 2026-04-22 from $2.60 to $3.70, also with a Neutral rating. The recent trend is mixed but currently softer, with Wall Street basically taking a wait-and-see stance rather than a bullish one. Pros: neutral rating avoids outright bearishness and target still sits above the current price. Cons: the latest target cut signals fading confidence and limited upside, with no strong buy case from analysts.
